Chiron Corp

Basic Information

4560 Horton St
Emeryville, CA, 94608

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. CYTOMEGALOVIRUS GLYCOPROTEIN B RECOMBINANT ANTIGENS

    Amount: $49,961.00

    THIS RESEARCH WILL EXPRESS RECOMBINANT FORMS OF HUMAN CYTOMEGALOVIRUS (CMV) GLYCOPROTEIN B (GB) FOR USE IN THE DEVELOPMENT OF A SUBUNIT VACCINE AGAINST CMV. IN VITRO MUTAGENESIS AND OTHER RECOMBINANT ...

    SBIR Phase I 1990 Department of Health and Human Services
  2. DEVELOPMENT OF A CYTOMEGALOVIRUS SUBUNIT VACCINE

    Amount: $49,873.00

    CHIRON CORPORATION IS DEVELOPING A SUBUNIT VACCINE DIRECTED AGAINST HUMAN CYTOMEGALOVIRUS (CMV), USING RECOMBINANT DERIVATIVES OF VIRAL GLYCOPROTEINS THAT ARE CAPABLE OF INDUCING NEUTRALIZING ANTIBODI ...

    SBIR Phase I 1990 Department of Health and Human Services
  3. DEVELOPMENT OF A DEFECTIVE HEPATITIS A VIRUS VACCINE

    Amount: $50,000.00

    ATTEMPTS TO GENERATE HEPATITIS A VIRUS (HAV) VACCINES HAVE BEEN UNSUCCESSFUL TO DATE DUE TO SEVERAL FACTORS, INCLUDING POOR GROWTH OF THE VIRUS IN TISSUE CULTURE, ABSENCE OF IN VITRO MARKERS OF ATTENU ...

    SBIR Phase I 1990 Department of Health and Human Services
  4. GENETIC ENGINEERING APPROACHES FOR MALARIA VACCINES

    Amount: $500,000.00

    THIS RESEARCH WILL DEVELOP SUBUNIT VACCINES FOR THE TWO PREDOMINANT SPECIES OF MALARIA PARASITES, PLASMODIUM FALCIPARUM AND PLASMODIUM VIVAX. PREVIOUS STUDIES HAVE SHOWN THAT: 1. HYBRID HEPATITIS B VI ...

    SBIR Phase II 1988 Department of Health and Human Services
  5. GENETIC ENGINEERING APPROACHES FOR AIDS VACCINES (MICE, RABB

    Amount: $246,000.00

    WE HAVE MOLECULARLY CLONED, SEQUENCED, AND EXPRESSED THE GENES OF THE RETROVIRUS ASSOCIATED WITH ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS), AND WE HAVE INITIATED GENETIC ENGINEERING APPROACHES FOR TH ...

    SBIR Phase II 1987 Department of Health and Human Services
  6. GENETIC ENGINEERING APPROACHES FOR MALARIA VACCINES

    Amount: $50,000.00

    N/A

    SBIR Phase I 1986 Department of Health and Human Services
  7. IN ORDER TO FACILITATE THE ULTIMATE PRODUCTION OF A DIAGNOSTIC AND VACCINE FOR HUMAN VIRAL NANB HEPATITIS USING RECOMBINANT DNA TECHNOLOGY, STRATEGIES DESIGNED TO ISOLATE VIRAL NUCLEIC ACID WILL BE INITIATED THROUGH THE PRODUCTION OF ENRICHED RECOMBINANT

    Amount: $50,000.00

    IN ORDER TO FACILITATE THE ULTIMATE PRODUCTION OF A DIAGNOSTIC AND VACCINE FOR HUMAN VIRAL NANB HEPATITIS USING RECOMBINANT DNA TECHNOLOGY, STRATEGIES DESIGNED TO ISOLATE VIRAL NUCLEIC ACID WILL BE IN ...

    SBIR Phase I 1985 Department of Health and Human Services
  8. A NEW APPROACH FOR ANTIGEN PRESENTATION AND POLYVALENT VACCINES IS PROPOSED.

    Amount: $37,095.00

    A NEW APPROACH FOR ANTIGEN PRESENTATION AND POLYVALENT VACCINES IS PROPOSED. EXPERIMENTS ARE DESIGNED TO TEST THE IDEA OF COMBINING THE GENE OF A SECOND IMMUNOGEN WITH THAT OF HEPATITIS B SURFACE ANTI ...

    SBIR Phase I 1985 Department of Health and Human Services
  9. GENETIC ENGINEERING APPROACHES FOR AIDS VACCINES (MICE, RABB

    Amount: $50,000.00

    N/A

    SBIR Phase I 1985 Department of Health and Human Services
  10. FEEDBACK CONTROLLED OLIGONUCLEOTIDE SYNTHESIZER PHASE I

    Amount: $221,047.00

    THE INVESTIGATIONS HAVE PROPOSED THE DEVELOPMENT OF AN AUTOMATED OLIGONUCLEOTIDE SYNTHESIZER INCORPORATING A NUMBEROF NEW FEATURES. USING PHOSPHITE-TRIESTER METHODOLOGY FOR OLIGODEOXYRIBONUCLEOTIDE SY ...

    SBIR Phase II 1984 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government